Karyopharm to pursue FDA approval for multiple myeloma drug based on new study results

A typically reliable method of securing U.S. approval for a cancer drug these days is to run a small, single-arm clinical trial

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readPolitics
Pelosi’s Drug Pricing Plan Would Let Medicare Negotiate Prices For Up To 250 Drugs
The new legislation is more aggressive than prior concepts that had circulated among lobbyists and congressional staff this year.
STAT3 min readScience
Amid Privacy Concerns, Startup Becomes First Consumer DNA Company To Offer Anonymous Sequencing
Nebula will offer anonymous testing amid public concerns about the privacy of genetic data and law enforcement use of public DNA databases to identify suspects.
STAT5 min readTech
Opinion: Tech Companies’ Dangerous Practice: Using Artificial Intelligence To Mine Hidden Health Data
Like modern day alchemists turning lead into gold, tech companies use machine learning to transform our digital traces into valuable and unprotected health data.